SQZ Biotechnologies Company (SQZB)
OTCMKTS · Delayed Price · Currency is USD
0.0280
0.00 (0.00%)
Aug 1, 2025, 2:58 PM EDT
CTI BioPharma Market Cap
SQZB has a market cap or net worth of $825.75 thousand as of August 1, 2025. Its market cap has increased by 18.90% in one year.
Market Cap
825.75K
Enterprise Value
n/a
Revenue
12.12M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.03
Market Cap Chart
Since October 30, 2020, SQZB's market cap has decreased from 317.63M to 825.75K, a decrease of -99.74%. That is a compound annual growth rate of -71.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 825.75K | -6.67% |
| Dec 31, 2024 | 884.73K | 50.75% |
| Dec 29, 2023 | 586.87K | -97.31% |
| Dec 30, 2022 | 21.79M | -91.30% |
| Dec 31, 2021 | 250.64M | -65.01% |
| Dec 31, 2020 | 716.30M | 125.51% |
| Oct 30, 2020 | 317.63M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.80B |
| Veradigm | 823.67M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 519.96M |
| Glass House Brands | 396.28M |
| Northwest Biotherapeutics | 376.73M |
| Nika Pharmaceuticals | 366.89M |
| CytoDyn | 366.82M |